Compare Stocks: GRI vs. JAGX vs. VRAX vs. APVO
Compare normalized stock price performance over 6 months, 1 year or 2 years. Each line starts at 0%, so different stock prices can be compared on the same scale.
GRIJAGXVRAXAPVO
Market Snapshot
Current market context for the selected companies.
GRI
$1.65
Market Cap
$3.61M
Sector
Healthcare
Industry
Biotechnology
Data through
2026-08-21
JAGX
$0.87
Market Cap
$4.26M
Sector
Healthcare
Industry
Biotechnology
Data through
2026-08-21
VRAX
$3.19
Market Cap
$2.54M
Sector
Healthcare
Industry
Biotechnology
Data through
2026-08-21
APVO
$2.68
Market Cap
$4.83M
Sector
Healthcare
Industry
Biotechnology
Data through
2026-08-21
Performance
Absolute returns and relative performance versus SPY.
| Metric | GRI | JAGX | VRAX | APVO |
|---|---|---|---|---|
| 1 Month | +10.0% | -15.8% | -0.0% | -38.7% |
| 1 Month vs SPY | +6.3% | -19.5% | -3.7% | -42.4% |
| 3 Months | -25.0% | -75.0% | -58.3% | -46.8% |
| 3 Months vs SPY | -28.1% | -78.1% | -61.4% | -49.9% |
| 6 Months | -33.7% | -95.9% | -40.1% | -59.8% |
| 6 Months vs SPY | -44.8% | -107.0% | -51.2% | -70.8% |
| 1 Year | -95.9% | -98.7% | -83.3% | -92.4% |
| 1 Year vs SPY | -115.9% | -118.7% | -103.3% | -112.4% |
| 2 Years | -99.3% | -99.9% | -94.0% | -100.0% |
| 2 Years vs SPY | -137.4% | -138.1% | -132.1% | -138.1% |
Growth & Profitability
Operating growth, margins and capital efficiency.
Valuation
Common valuation multiples shown side by side.
Cash Flow & Balance Sheet
Cash generation and leverage context.
Earnings Outlook
Upcoming earnings expectations when available.